Home › Funds › Citadel Advisors › NRIX
Citadel Advisors position in NRIX
NURIX THERAPEUTICS INC COM · Health Care
Latest position (Q2 2026)11.40K sh
Reported value held$276.56K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 52.11K | $1.56M | New |
| Q4 2021 | 63.28K | $1.83M | Add |
| Q1 2022 | 298.88K | $4.19M | Add |
| Q2 2022 | 112.10K | $1.42M | Reduce |
| Q3 2022 | 219.18K | $2.86M | Add |
| Q4 2022 | 262.81K | $2.89M | Add |
| Q1 2023 | 211.29K | $1.88M | Reduce |
| Q2 2023 | 152.67K | $1.53M | Reduce |
| Q3 2023 | 85.97K | $675.71K | Reduce |
| Q4 2023 | 49.87K | $514.65K | Reduce |
| Q1 2024 | 220.22K | $3.24M | Add |
| Q2 2024 | 1.09M | $22.67M | Add |
| Q3 2024 | 1.56M | $35.01M | Add |
| Q4 2024 | 891.02K | $16.79M | Reduce |
| Q1 2025 | 1.33M | $15.81M | Add |
| Q1 2025 | 1.33M | $15.81M | Add |
| Q2 2025 | 1.64M | $18.68M | Add |
| Q2 2025 | 1.64M | $18.68M | Add |
| Q3 2025 | 605.80K | $5.60M | Reduce |
| Q4 2025 | 1.19M | $22.52M | Add |
| Q1 2026 | 1.38M | $21.39M | Add |
| Q2 2026 | 11.40K | $276.56K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Vestal Point Capital, LP 8.05M sh · $195.29M · Q2 2026
- Deep Track Capital, LP 7.74M sh · $187.69M · Q2 2026
- Rubric Capital Management LP 7.23M sh · $175.35M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 5.44M sh · $131.89M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- BAKER BROS. ADVISORS LP 4.66M sh · $113.02M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 4.50M sh · $109.06M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.32M sh · $104.81M · Q2 2026
- Redmile Group, LLC 4.07M sh · $98.83M · Q2 2026